{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:10:29Z","timestamp":1788232229662,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016185","name":"Aimmune Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jaci.2023.01.001","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T21:19:09Z","timestamp":1674163149000},"page":"590-594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Might biologics serve to interrupt the atopic march?"],"prefix":"10.1016","volume":"151","author":[{"given":"Jonathan M.","family":"Spergel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Du Toit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2023.01.001_bib1","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/j.jaci.2003.09.033","article-title":"Atopic dermatitis and the atopic march","volume":"112","author":"Spergel","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.anai.2009.10.002","article-title":"From atopic dermatitis to asthma: the atopic march","volume":"105","author":"Spergel","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.anai.2021.06.004","article-title":"Thymic stromal lymphopoietin, skin barrier dysfunction, and the atopic march","volume":"127","author":"Ziegler","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib4","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1172\/JCI1647","article-title":"Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice","volume":"101","author":"Spergel","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2023.01.001_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.anai.2021.04.036","article-title":"One march, many paths: insights into allergic march trajectories","volume":"127","author":"Gabryszewski","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaci.2018.11.006","article-title":"The atopic march and atopic multimorbidity: many trajectories, many pathways","volume":"143","author":"Paller","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib7","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jaci.2011.02.041","article-title":"Childhood eczema and rhinitis predict atopic but not nonatopic adult asthma: a prospective cohort study over 4 decades","volume":"127","author":"Martin","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/pai.12410","article-title":"Allergic multimorbidity of asthma, rhinitis and eczema over 20 years in the German birth cohort MAS","volume":"26","author":"Gough","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaci.2007.05.042","article-title":"Risk of developing asthma in young children with atopic eczema: a systematic review","volume":"120","author":"van der Hulst","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.anai.2017.12.016","article-title":"Can the atopic march be predicted?","volume":"120","author":"Tran","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jaci.2017.08.024","article-title":"Predicting the atopic march: results from the Canadian Healthy Infant Longitudinal Development Study","volume":"141","author":"Tran","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib12","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jaci.2017.09.044","article-title":"Identification of atopic dermatitis subgroups in children from 2 longitudinal birth cohorts","volume":"141","author":"Paternoster","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/jamapediatrics.2017.0556","article-title":"Phenotypes of atopic dermatitis depending on the timing of onset and progression in childhood","volume":"171","author":"Roduit","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaci.2023.01.001_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001748","article-title":"Developmental profiles of eczema, wheeze, and rhinitis: two population-based birth cohort studies","volume":"11","author":"Belgrave","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.jaci.2023.01.001_bib15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/pde.12867","article-title":"Study of the atopic march: development of atopic comorbidities","volume":"33","author":"Schneider","year":"2016","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaci.2023.01.001_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jaci.2013.03.043","article-title":"Filaggrin gene mutation associations with peanut allergy persist despite variations in peanut allergy diagnostic criteria or asthma status","volume":"132","author":"Asai","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.08.011","article-title":"Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations","volume":"134","author":"Brough","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib18","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jaci.2017.09.034","article-title":"Allergen specificity of early peanut consumption and effect on development of allergic disease in the Learning Early About Peanut Allergy study cohort","volume":"141","author":"du Toit","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib19","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/ng.3985","article-title":"Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology","volume":"49","author":"Ferreira","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2023.01.001_bib20","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1038\/s41598-018-21459-x","article-title":"Epistasis between FLG and IL4R Genes on the risk of allergic sensitization: results from two population-based birth cohort studies","volume":"8","author":"Ziyab","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2023.01.001_bib21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.immuni.2016.08.015","article-title":"Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species","volume":"45","author":"Guilliams","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2023.01.001_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng.547","article-title":"Common variants at 5q22 associate with pediatric eosinophilic esophagitis","volume":"42","author":"Rothenberg","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2023.01.001_bib23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature10329","article-title":"TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation","volume":"477","author":"Siracusa","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2023.01.001_bib24","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nm.3281","article-title":"Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis","volume":"19","author":"Noti","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2023.01.001_bib25","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/pai.13501","article-title":"Pathogenesis of IgE-mediated food allergy and implications for future immunotherapeutics","volume":"32","author":"Ramsey","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2020.106228","article-title":"Preventing asthma in high risk kids (PARK) with omalizumab: design, rationale, methods, lessons learned and adaptation","volume":"100","author":"Phipatanakul","year":"2021","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jaci.2023.01.001_bib27","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0140-6736(08)61451-8","article-title":"Early identification of atopy in the prediction of persistent asthma in children","volume":"372","author":"Sly","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2023.01.001_bib28","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jaci.2006.12.669","article-title":"Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma","volume":"119","author":"Kusel","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1164\/rccm.201104-0660OC","article-title":"Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life","volume":"185","author":"Jackson","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2023.01.001_bib30","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jaci.2012.05.023","article-title":"Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children","volume":"130","author":"Durrani","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib31","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.4049\/jimmunol.0901194","article-title":"Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells","volume":"184","author":"Gill","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib32","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1164\/rccm.200802-309OC","article-title":"Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children","volume":"178","author":"Jackson","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2023.01.001_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","article-title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","volume":"143","author":"Guttman-Yassky","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib34","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jaci.2014.10.013","article-title":"Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis","volume":"134","author":"Hamilton","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jid.2019.05.024","article-title":"IL-4Ralpha blockade by dupilumab decreases Staphylococcus aureus colonization and increases microbial diversity in atopic dermatitis","volume":"140","author":"Callewaert","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.01.001_bib36","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3390\/microorganisms9071487","article-title":"Changes in skin and nasal microbiome and staphylococcal species following treatment of atopic dermatitis with dupilumab","volume":"9","author":"Olesen","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.jaci.2023.01.001_bib37","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/all.14027","article-title":"New biological treatments for asthma and skin allergies","volume":"75","author":"Eyerich","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2023.01.001_bib38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40265-022-01679-2","article-title":"Tezepelumab: first approval","volume":"82","author":"Hoy","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.jaci.2023.01.001_bib39","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S2213-2600(21)00537-3","article-title":"Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study","volume":"10","author":"Wechsler","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2023.01.001_bib40","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/jid.2012.239","article-title":"TSLP produced by keratinocytes promotes allergen sensitization through skin and thereby triggers atopic march in mice","volume":"133","author":"Leyva-Castillo","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.01.001_bib41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaci.2017.02.046","article-title":"Prevention of food allergy development and suppression of established food allergy by neutralization of thymic stromal lymphopoietin, IL-25, and IL-33","volume":"141","author":"Khodoun","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.01.001_bib42","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S2213-2600(21)00226-5","article-title":"Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"9","author":"Diver","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2023.01.001_bib43","unstructured":"Center for Drug Evaluation and Research, Application number: 761180Orig1s000. Labeling. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2022\/761180Orig1s000lbl.pdf. Accessed October 15, 2022."},{"key":"10.1016\/j.jaci.2023.01.001_bib44","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2213-2600(18)30201-7","article-title":"Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial","volume":"6","author":"Russell","year":"2018","journal-title":"Lancet Respir Med"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923000052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923000052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:43:20Z","timestamp":1758793400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674923000052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0091674923000052"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2023.01.001","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Might biologics serve to interrupt the atopic march?","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2023.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma Immunology","name":"copyright","label":"Copyright"}]}}